Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Munich Surgical Imaging (MSI) is a medical technology company specializing in the development of advanced digital surgical microscopy and visualization solutions. The company's core technology integrates high-definition 3D imaging with augmented reality (AR) to provide surgeons with enhanced anatomical detail and real-time data overlays during complex procedures. MSI's flagship technology is central to the ARveo digital microscope series, developed in a long-standing collaboration with Leica Microsystems. Following its acquisition by Aesculap AG (a B. Braun company) in 2022, MSI continues to innovate in the field of robotic-assisted and digitally-enhanced surgical workflows. The company's products are primarily utilized in neurosurgery, ENT, and ophthalmic surgeries to improve surgical precision and outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Munich Surgical Imaging.